New study tracks rare brain disease in children to pave way for future treatments

NCT ID NCT05825131

First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study follows 30 children and young adults with Sanfilippo syndrome type C, a rare genetic disorder that causes severe brain damage. Researchers will measure changes in development and thinking skills over time using standard tests. The goal is to better understand how the disease progresses, which can help design future clinical trials for potential treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to
If successful, this study will provide crucial data on how Sanfilippo syndrome type C progresses, which could help design future treatments.
What could go wrong
This is an observational study, not a treatment trial. It will not directly improve symptoms or slow the disease. Results may take years to impact care.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for SANFILIPPO SYNDROME TYPE C are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Mucopolysaccharidosis III mucopolysaccharidosis type 3C

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

Contacts and locations

Locations

  • Hospices Civils De Lyon

    RECRUITING

    Bron, 690007539, France

  • The University of Texas Southwestern Medical Center

    RECRUITING

    Dallas, Texas, 75390, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.